Current status of yttrium-90 microspheres radioembolization in primary and metastatic liver cancer [PDF]
Journal of Interventional Medicine, 2023 Liver malignancy, including primary liver cancer and metastatic liver cancer, has become one of the most common causes of cancer-related death worldwide due to the high malignant degree and limited systematic treatment strategy.
Feng Duan +2 more
exaly +7 more sources
Advances in SPECT for Optimizing the Liver Tumors Radioembolization Using Yttrium-90 Microspheres
World Journal of Nuclear Medicine, 2015 Radioembolization (RE) with Yttrium-90 ( 90 Y) microspheres is an effective treatment for unresectable liver tumors. The activity of the microspheres to be administered should be calculated based on the type of microspheres.
Hoda Roshan +3 more
doaj +3 more sources
EJNMMI Physics, 2022 Purpose To perform precision dosimetry in yttrium-90 radioembolization through CT imaging of radiopaque microspheres in a rabbit liver model and to compare extracted dose metrics to those produced from conventional PET-based dosimetry.
Kimberly Brewer +2 more
exaly +3 more sources
Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres [PDF]
EJNMMI Physics, 2021 Background Multiple post-treatment dosimetry methods are currently under investigation for Yttrium-90 ( $$^{90}\hbox {Y}$$ 90 Y ) radioembolization.
S. Peter Kim +3 more
doaj +2 more sources
Successful treatment with yttrium-90 microspheres in a metastatic breast cancer patient and sclerosing cholangitis [PDF]
Future Science OA, 2021 Breast cancer is the most common malignancy occurring in women worldwide. More than 90% of patients present with localized disease are treated with curative intent; however, recurrence can occur with development of metastatic lesions.
Aurélie Louvet +3 more
doaj +2 more sources
Radiation segmentectomy with resin microspheres for hepatocellular carcinoma: a state-of-the-art review highlighting evidence gaps and future research needs [PDF]
EJNMMI PhysicsIntroduction Radiation segmentectomy (RS) has emerged as a promising approach for hepatocellular carcinoma (HCC), particularly when high tumor doses are achieved.
Javier Orcajo Rincón +10 more
doaj +2 more sources
Frontiers in Nuclear Medicine, 2022 This article aims at presenting in a didactic way, dosimetry concepts and methods that are relevant for radio-embolization of the liver with 90Y-microspheres.
Arnaud Dieudonné +4 more
doaj +1 more source
Radiochemical Feasibility of Mixing of 99mTc-MAA and 90Y-Microspheres with Omnipaque Contrast
Molecules, 2022 Yttrium-90 (90Y) microspheres are widely used for the treatment of liver-dominant malignant tumors. They are infused via catheter into the hepatic artery branches supplying the tumor under fluoroscopic guidance based on pre-therapy angiography and ...
Chang-Tong Yang +6 more
doaj +1 more source
Radioembolization for hepatocellular carcinoma: what clinicians need to know [PDF]
Journal of Liver Cancer, 2022 Transarterial radioembolization (TARE) with yttrium 90 (90Y) has been used in the management of hepatocellular carcinoma (HCC) for more than 10 years in Korea.
Jin Woo Choi, Hyo-Cheol Kim
doaj +1 more source
Diagnostic and Interventional Radiology, 2023 PURPOSETo analyze changes in angiogenesis factors after transarterial radioembolization (TARE) with Yttrium- 90-loaded resin microspheres in hepatocellular carcinoma (HCC) patients.METHODSInterleukin-6, interleukin-8, hepatocyte growth factor, platelet ...
Hüseyin Tuğsan Ballı +3 more
doaj +1 more source